Gene expression profiling of skin and blood in hidradenitis suppurativa
Authors:
- 2 March 2016
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 174 (6) , 1392-1394
Abstract
No abstract availableFunding Information
- Janssen Cilag Inc.
This publication has 10 references indexed in Scilit:
- Compartmentalized Cytokine Responses in Hidradenitis SuppurativaPLOS ONE, 2015
- The prevalence of metabolic syndrome in patients with hidradenitis suppurativaJournal of the American Academy of Dermatology, 2014
- Impaired Notch‐MKP‐1 signalling in hidradenitis suppurativa: an approach to pathogenesis by evidence from translational biologyExperimental Dermatology, 2013
- Impact of Toll-like receptor-4 and tumour necrosis factor gene polymorphisms in patients with hidradenitis suppurativaBritish Journal of Dermatology, 2012
- Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativaJournal of the American Academy of Dermatology, 2011
- Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesionsBritish Journal of Dermatology, 2011
- PSENEN and NCSTN Mutations in Familial Hidradenitis Suppurativa (Acne Inversa)Journal of Investigative Dermatology, 2011
- Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1βBritish Journal of Dermatology, 2011
- γ-Secretase Gene Mutations in Familial Acne InversaScience, 2010
- Increased Serum Tumour Necrosis Factor- in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor- Agents?Acta Dermato-Venereologica, 2009